Occupational Therapists in La Habra, CA Accepting Medicare

6 Occupational Therapists found. Showing 1 - 6

Ms. Theresa Hellstrom Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1760 Woodcrest Ave, La Habra, CA 90631 Phone: 714-585-5202

Mrs. Irene Wong Uota, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Vernon St, La Habra, CA 90631 Phone: 562-697-7751

Angela Lee, MA Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1320 W Player Ave, La Habra, CA 90631 Phone: 714-403-5520

Jc Frances Castillo Baloy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1770 W La Habra Blvd, La Habra, CA 90631 Phone: 562-691-8810

Paul Emerson Baloy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1770 W La Habra Blvd, La Habra, CA 90631 Phone: 562-691-8810

Mrs. Debbie Sue Grossman, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 971 S Idaho St Unit 16, La Habra, CA 90631 Phone: 562-500-1983    Fax: 562-697-4552

News Archive

Democratic speakers rally around health law

During Wednesday's convention proceedings, speakers criticized what they described as Republican plans to "voucher-ize Medicare" and touted provisions of the 2010 health law already in effect, such as coverage for children with pre-existing medical conditions, the closing Medicare Part D "doughnut hole" and the ability to keep young people on their parents' policies until age 26.

Auditory feedback pathway in the brain linked to learned vocal control identified

Scientists at Duke University Medical Center have identified neurons in the songbird brain that convey the auditory feedback needed to learn a song.

Transforming biomedical research to develop TB vaccines

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Angioslide commercializes Proteus device for ECA in the U.S.

Angioslide, Inc. of Minneapolis, MN and Angioslide, Ltd. Herzliya, Israel, announced today that the company has commercialized the Proteus device for Embolic Capture Angioplasty in the United States. The device combines an angioplasty balloon and embolic capture feature into one device, thus providing physicians with a simple and cost-effective method of capturing of embolic particles during angioplasty procedures.

Read more Medical News

› Verified 3 days ago